Surgical treatment of vestibular schwannoma is targeted at complete removal with preserved neurological function. Complete removal may cause significant deficits, whereas subtotal tumor removal is associated with a high recurrence rate. The present study assessed the risk of tumor recurrence and postoperative facial nerve function in relation to the extent of surgical resection by reviewing the clinical records and radiological findings of 116 patients with vestibular schwannoma treated between 1990 and 1999. The extent of resection was classified as follows: gross total resection (GTR), near total resection (NTR), and subtotal resection (STR). Facial nerve function was graded using the modified House-Brackmann grade, and patients grouped into good (grades 1-2) and intermediate or poor (grades 3-6). Of the 116 patients, 26 (22%) underwent GTR, 32 (28%) NTR, and 58 (50%) STR. The recurrence rates were 3.8% (1/26 cases), 9.4% (3/32), and 27.6% (16/58) for GTR, NTR, and STR, respectively. GTR and NTR showed no statistically significant difference in terms of recurrence rate (p ＝ 0.620). However, recurrence was significantly less after NTR than STR (p ＝ 0.043). Immediately postoperative facial nerve function was good in 15.4% of patients after GTR, 40.6% after NTR, and 46.6% after STR. The STR and NTR carried a lower risk of facial nerve palsy than GTR in the immediately postoperative stage (p ＝ 0.006 and 0.036, respectively). Nevertheless, no statistical significance was observed in extent of resection and postoperative facial nerve outcome between the groups at last follow up (p ＝ 0.227). GTR is the ideal surgical treatment for vestibular schwannoma, but NTR is a good option, with better facial nerve function preservation than GTR without significantly increasing the risk of recurrence.
Introduction
The neurosurgical treatment of vestibular schwannoma (VS) has two major goals: complete tumor removal and the preservation of facial nerve function. 5) Improved surgical methods now allow complete tumor removal with lower morbidity and mortality, but complete tumor removal carries a significant risk of facial nerve injury. The incidence of postoperative facial nerve palsy remains high at 37% to 80%, particularly for large tumors. 1, 2, 12) Partial tumor removal is less likely to cause facial nerve palsy, but the risk of tumor recurrence is high at 20% to 80%. 5, 12) However, several recent studies have indicated that incomplete resection is not associated with a significant increase in recurrence rate. 5, 9, 10, 12) This retrospective study examined the recurrence rate and postoperative facial nerve function in relation to the extent of surgical resection.
Materials and Methods

I. Patient population
Three hundred thirty-six patients with VS were Table 1 .
II. Clinical features
The extent of tumor removal was evaluated using the operation records and postoperative magnetic resonance (MR) imaging. The degree of resection was classified as gross total resection (GTR), near total resection (NTR), and subtotal resection (STR). 5, 10) NTR was defined as remnants of intracanalicular tumor or tumor adhering to the facial nerve or brainstem. STR was defined as resection of less than 95% of the tumor. 10) GTR was performed only if a clear arachnoid plane was observed. If changes in intraoperative monitoring or vital signs during dissection of the tumor from the brainstem were detected, further radical extirpation was avoided. STR or NTR was planned in patients with advanced age or medical co-morbidities.
Facial nerve functions were graded using the modified House-Brackmann (H-B) grade, 7) and were obtained from postoperative records and the last follow-up examination. These grades were grouped into two categories: good (H-B grades 1-2), and intermediate or poor (H-B grades 3-6). 12) 
III. Neuroimaging findings
Initial tumor size was based on the greatest extracanalicular dimension on preoperative MR imaging or computed tomography. Patients also underwent MR imaging within 3 months of the surgery to evaluate the extent of removal. The current protocol is to obtain MR images at 3, 6, and 12 months after surgery, and every year thereafter. Tumor recurrence or regrowth was defined as an increase in the greatest dimension on follow-up imaging.
IV. Statistical analysis
Commercially available software (SPSS for Windows, version 11.0; SPSS Inc., Chicago, Ill., U.S.A.) was used for statistical evaluation. Statistical significance was determined using the Pearson's chi-square test. A value of p º 0.05 was considered significant. The Kaplan-Meier method was used to compare the recurrence rates for GTR, NTR, and STR over the follow-up periods. The log-rank test was used for analyses of the groups.
Results
I. Surgical approach
GTR was performed in 26 (22%) of the 116 patients, NTR in 32 (28%), and STR in 58 (50%). All patients underwent unilateral surgery. The suboccipital approach was used in 100, the translabyrinthine approach in 11, the transcochlear approach in two, and the posterior transpetrosal approach in three. The suboccipital approach offers excellent exposure of the posterior fossa in most cases of large VS, but exposure of the internal auditory canal, especially the lateral one third, is hampered by the posterior semicircular canal and vestibule. The translabyrinthine approach offers excellent exposure of the internal auditory canal as well as the posterior fossa, but the auditory nerve has to be sacrificed. Therefore, this approach was used in not so large tumors (º3 cm) and in patients with deafness. The transcochlear or posterior transpetrosal approach was used for large tumors (À5 cm) which extended into the middle fossa.
Postoperative complications are shown in Table 2 . There was no remarkable difference between the three groups. Only two cases of surgeryrelated mortality due to cerebral infarction occurred in the GTR group. GTR: gross total resection. 
II. Hearing and trigeminal nerve preservation
Because most of the tumors were large, unserviceable hearing loss (pure-tone audiogram threshold AE50 dB) was detected preoperatively in 111 of 116 patients. Therefore, our surgical strategy was to remove the tumors as far as possible and to preserve the facial nerve, rather than to preserve the hearing, in many patients. Hearing was preserved in only two of the five patients (40%) with preoperative serviceable hearing loss. Disturbance of trigeminal nerve function was found as preoperative eye dryness in eight patients (6.9%), and postoperative eye dryness in 22 (19%).
III. Tumor size and regrowth
The mean tumor size was 39.6 mm (range 21 to 70 mm). The mean tumor size was 37.2 mm, 41.1 mm, and 39.5 mm in the GTR, NTR, and STR groups, respectively. Tumor size was not statistically related to recurrence (p ＝ 0.12) or extent of resection (p ＝ 0.31). However, tumor size was significantly related to postoperative deterioration of facial nerve function (p ＝ 0.001). The relationships between tumor size and extent of tumor removal, facial nerve preservation, and recurrence rate are summarized in Table 3 .
The overall growth rate of residual tumors was 0.6 mm/yr in the 81 patients with residual tumor on MR imaging at follow up of more than 2 years. The annual growth rate after STR (N ＝ 48) was 0.8 mm/yr.
IV. Recurrence rate and the extent of resection
The recurrence rates for the GTR, NTR, and STR groups were 3.8% (1/26 cases), 9.4% (3/32), and 27.6% (16/58), respectively, and the time to recurrence ranged from 6 to 143 months (median 22 months). Ten patients with recurrent tumor underwent reoperation and 16 patients underwent stereotactic radiosurgery. Overall, the extent of resection was significantly related to the recurrence rate by Pearson's chi-square test (p ＝ 0.01). There was no statistically significant difference between the recurrence rates of the GTR and NTR groups (p ＝ 0.620). Nonetheless, the NTR and GTR groups showed less recurrence than the STR group (p ＝ 0.043 and 0.012, respectively). The recurrence-free survival curve showed a significant difference between the three groups (p ＝ 0.003) (Fig. 1) . All recurrences arose from residual tumors in the internal auditory canal in the patients with NTR or STR.
V. Postoperative facial nerve function
Preoperative and postoperative (immediately after operation and at last follow up) facial nerve function is summarized in Table 4 . Immediately postoperative facial nerve function was good in 13 (40.6%) of the 32 patients in the NTR group and in 27 (46.6%) of the 58 in the STR group, in contrast to four (15.4%) of the 26 in the GTR group. The extent of resection was significantly related to postoperative facial Good facial nerve function was preserved immediately after surgery in four (16.0%) of the 25 patients with good preoperative nerve function in the GTR group, 13 (48.1%) of 27 in the NTR group, and 27 (50.9%) of 53 in the STR group. The STR and NTR groups had a lower incidence of facial nerve palsy than the GTR group (p ＝ 0.006 and 0.036, respectively). There was no significant difference between the STR and NTR groups (p ＝ 0.588).
Facial nerve outcomes differed at the last follow up from the immediate postoperative results. Facial nerve function showed improvement in some patients. No statistical significance was observed between the extent of resection and postoperative facial nerve outcome (p ＝ 0.227).
Discussion
Most of our patients underwent VS surgery for tumor removal with the aim of preservation of the facial nerve function. Only four patients required hearing saving operation, of whom one achieved serviceable hearing (pure-tone average º50 dB, speech discrimination score À50%). 15) Our findings suggest that the risk of tumor recurrence after NTR is quite low. Substantial adherence of the tumor to the facial nerve presents a high risk of poor facial nerve outcome. Incomplete resection is helpful for preserving facial nerve integrity because the enlarged tumor compresses the facial nerve and the tumor-arachnoid membrane plane is lost. 3) Therefore, we tried to assess recurrence and postoperative facial nerve function in relation to the extent of surgical resection.
I. Tumor recurrence
Two previous studies have been conducted on the risk of recurrent tumor in relation to resection using similar GTR, NTR, and STR group definitions to the present study. Recurrence rates of 29% and 25% were reported for NTR (90-99% resection) and STR, respectively, but no recurrence occurred following GTR. 13) Recurrence rates were 12% and 65% for NTR (95-99% resection) and STR, respectively, with no recurrence after more than 98% resection. 5) These different recurrence rates for NTR and STR may have resulted from the use of different definitions for the extent of tumor resection. 13) In the present study, NTR was defined as 95% to 99% tumor resection, with remnant tumor at the intracanalicular origin or adhering to the facial nerve or brainstem. Our recurrence rates were 3.8% for GTR, 9.4% for NTR, and 27.6% for STR, and the extent of resection was significantly related to the recurrence rate (p ＝ 0.01). Only three recurrences occurred among patients who underwent NTR, whereas 29 patients showed no recurrence, and no statistically significant difference was observed between the recurrence rates of the GTR and NTR groups (p ＝ 0.620). The NTR group showed less recurrence than the STR group (p ＝ 0.043). Therefore, GTR is not always necessary and NTR is sufficient for prevention of recurrence. Thus, NTR is a good surgical strategy for VS in terms of recurrence risk. In contrast, STR is associated with a substantially higher risk of recurrence.
The low recurrence rate after NTR may be due to the results of surgical devascularization. The growth rate of VS appears to be governed by many factors, such as patient age, tumor size, and presence of von Recklinghausen's disease. However, cellularity and vascularity also affect growth rate. 8, 9) Vascularization occurs due to tumor angiogenesis within VS larger than 2 cm. The principal factor affecting the postoperative growth potential of residual tumor is vascularity rather than cellularity. 9) The low recurrence rate of intracanalicular residual tumor is attributed to the devascularizing effect of surgery.
II. Facial nerve preservation
In our study, tumor size was significantly related to postoperative facial nerve function (p ＝ 0.001). The correlation between postoperative facial nerve function and tumor size is generally accepted. 7, 9) The incidence of facial nerve palsy was 80% for tumors greater than 2 cm in diameter. 11) The incidence of postoperative facial nerve paresis or paralysis was 46% for large tumors greater than 3 cm in diameter. 14) Tumor size is the most important predictor of facial nerve palsy. 6) Other predictors of facial nerve function are displacement of the fourth ventricle, image heterogeneity (necrosis, edema, cystic change), and the threshold stimulus eliciting a facial nerve response. 4) H. J. Seol et al.
Good postoperative facial nerve function was achieved in 44.4% of patients after NTR or STR, in contrast to 15.4% after GTR, which is worse than outcomes previously reported. 10) The reason may be related to the majority of large tumors in the present study. However, we found that the extent of resection was significantly related to postoperative facial nerve outcome (p ＝ 0.010), and NTR had a lower risk of facial nerve palsy than GTR (p ＝ 0.036). Thus, we propose that NTR is a good surgical strategy for VS, as it provides more opportunity for preserving facial nerve function.
III. Conclusion
GTR is the ideal surgical treatment for VS, but carries a significant risk of facial nerve dysfunction. NTR (95% to 99% resection) is a good strategy with high likelihood of preserving facial nerve function without significantly increasing the risk of recurrence.
